Recent data from the National Suicide Observatory, reported by Le Monde, reveals that 25 people take their lives daily in France. Suicide often stems from untreated mental health challenges, leaving loved ones grappling with grief and confusion. However, groundbreaking research from Binghamton University in New York offers hope: a potential blood test could identify suicide risk through biological markers.
The study examined 73 mothers—34 with a history of intentional self-harm aimed at suicide and 39 with no such history. Analyzing their blood samples, researchers found that those with suicidal behaviors had significantly lower levels of BDNF, a protein essential for neuronal development and synaptic plasticity.
This blood test could soon become routine. "A nurse or doctor would draw blood, just as they do now," explains Dr. Leigh, a key researcher on the study. "It measures BDNF levels, which support synaptic plasticity—the evolution and function of neurons. Impaired plasticity is linked to dark thoughts."
While initial results are promising, larger studies over several years are needed. Dr. Leigh is optimistic: early detection could enable regular monitoring and timely treatment for depression, providing crucial support to those who suffer silently. This approach could save lives—fingers crossed for continued progress.
